DexCom/DXCM

$116.44

0.15%
-
1D1W1MYTD1YMAX

About DexCom

DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.

Ticker

DXCM

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Kevin Sayer

Employees

9,600

Headquarters

San diego, United States

DexCom Metrics

BasicAdvanced
$44.82B
Market cap
90.69
P/E ratio
$1.28
EPS
1.18
Beta
-
Dividend rate

What the Analysts think about DexCom

Analyst Ratings

Majority rating from 23 analysts.
Buy

Price Targets

Average projection from 21 analysts.
27.43% upside
High $170.00
Low $122.00
$116.44
Current price
$148.38
Average price target

DexCom Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
24.77% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$1.03B
6.1%
Net income
$256.3M
112.34%
Profit margin
24.77%
100.24%

DexCom Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 15.87%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.17
$0.34
$0.50
$0.50
-
Expected
$0.15
$0.23
$0.34
$0.43
$0.27
Surprise
16.09%
50.3%
46.74%
15.87%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell DexCom stock

Buy or sell DexCom stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing